Preference-based versus randomized controlled trial in prostate cancer survivors: Comparison of recruitment, adherence, attrition, and clinical outcomes.

Front Oncol · 2022 · PMC9791189 · PMID 36578945

Europe PMC DOI

hedged sentence

0.3200

closest p · 6.4× alpha

0.3200

boldest claim

The sentences

did not reach statistical significancep=0.32not close (p > 0.1)

Retention was numerically higher in HOME (78.4%) than GROUP (64.7%) at 6 months but did not reach statistical significance (p=0.32).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.